Is long-acting repeatable octreotide an effective primary therapy for patients with acromegaly?
Bonert
Vivien S
VS
Department of Medicine at Cedars Sinai Medical Center, David Geffen School of Medicine, University of California, Los Angeles, CA 90048, USA. vivien.bonert@cshs.org